Nora Frey
Venture Partner at Seventure Partners
Nora Frey
Venture Partner at Seventure Partners
Binningen, Basel-Country
Overview
Work Experience
Venture Partner
2019 - Current
At Seventure Partners, we turn innovation into entrepreneurial ventures through financial backing and by sharing the passion of the companies we invest in. Established in 1997, Seventure Partners is one of the European leaders in venture capital, with €850 million net commitments under management as of the end of 2020. We actively fund innovative companies within the two evolving fields of Digital technologies and Life sciences, partnering with those that have strong growth potential. Initially acting as advisor, Nora became Venture Partner in 2021. Nora represents Seventure on the boards of Citryll, Netherlands and Targedys, France.
Co-Founder and Director
2009
Licensing, sales and distribution of prescription pharmaceuticals and medical devices.
Founder and Director
2009
Giblot’s vision is to support, guide and build innovation in the nutritional and healthcare sectors on a global basis with a particular focus on Africa.
Advisor and Investment Director
2009 - 2019
An international healthcare investment firm that finances and enables innovative science and technology with the potential to transform healthcare. Sourcing, Due Diligence and Investment Advisory.
Founding Investor, Director and Chairperson
2010 - 2017
Nurevas International AG produces and markets a broad range of processed foods for the retail and food services sectors in sub-Saharan Africa. The company currently possesses operations in Switzerland and Ghana. The company was built from concept to a successful business. In 2015, Nurevas signed a Co-packing Agreement for West-Africa with Heinz Africa, for which Nora led the negotiations.
Founder and Director
2009 - 2014
A privately-owned, development-focused company, with extensive anti-infectives experience in research and development, was founded in 2009 in Basel, Switzerland and subsequently relocated to the UK.
Founder and Chief Investment Officer
2001 - 2008
A successful Healthcare Asset Management company focused on the most rapidly growing and profitable segments of the Health Care Industry, investing in the public and private companies. Several funds in the fields of Biotech, Speciality Pharma, Medtech, including an oncology focused fund. Investments were made across the world including Europe, US, Asia and Africa. At its peak, Adamant managed USD 1 billion in assets. Nora held board and chair seats.
Analyst and Portfoliomanager
1998 - 2000
BB Biotech invests in companies in the fast growing market of biotechnology and is one of the world's largest investors in this sector with more than 25 years of experience. Biotechinvestments Europe and US: Sourcing, Due Diligence, Portfoliomanagement.